Consequences of Underrepresentation in Clinical Trial Design

Ashley Moultrie featured in Applied Clinical Trials

Applied Clinical Trials recently published an article illuminating the consequences of underrepresentation in clinical trials and three foundational ways you and your organization can take action today. A healthier tomorrow requires a shared responsibility; we must hold each other accountable.

Hear more from Javara’s Ashley C Moultrie, CCRP in “The Consequences of Underrepresentation in Clinical Trial Design.” View the full article!